Utilization of Implantable Cardioverter-Defibrillators in Patients With Heart Transplant (from National Inpatient Sample Database)
Introduction
In its 2011 registry of approximately 70,000 heart transplant (HT) recipients worldwide, the International Society of Heart and Lung Transplantation demonstrated a median survival after first-time transplantation of roughly 11 years.1 Sudden cardiac death (SCD) has been recognized as a major cause of death in this population, with mortality rates ranging from 10% to 35%.2,3 Implantable cardioverter-defibrillators (ICDs) are routinely implanted for patients with left ventricular systolic function <35% to prevent SCD. However, there exists limited observational evidence regarding the role of ICDs in the setting of HT.2,4 The current American College of Cardiology/American Heart Association guidelines recommend ICD as a reasonable strategy for primary prevention after HT with severe allograft vasculopathy and graft dysfunction (class IIB).2 Given the limited evidence and uncertain benefit, clinical practice patterns of ICD placement have depended on physician judgment.5 We sought to evaluate the current trends in new ICD placement in the HT patient population, patient outcomes, and predictors of ICD placement. This was done through a retrospective analysis of all HT admissions receiving an ICD using the National Inpatient Sample (NIS) database.
Section snippets
Methods
This was a retrospective analysis of discharge data from the NIS from 2009 to 2018. The NIS is an all-payer database that approximates a 20% stratified sample of discharges from the United States community hospitals participating in the Healthcare Cost and Utilization Project (HCUP), sponsored by the Agency for Healthcare Research and Quality.6 It includes de-identified clinical and nonclinical elements such as primary and secondary diagnoses, patient demographics, payment source, length of
Results
Between 2009 and 2018, 22,673 hospitalizations were reported for heart transplantation, during which patients either received a concurrent new ICD placement (n = 70 [0.31%]) or no new ICD placement (n = 22,603 [99.7%]) (Table 1). The mean age of the cohort studied was 53.3 (SE:0.22), and 5,997 (26.5%) of hospitalizations were female (Table 1). Baseline and clinical characteristics did not significantly differ between groups.
An overall non-significant decline was observed in the unadjusted
Discussion
This large, retrospective, and multicenter analysis provides an overview regarding the implantation of ICD in HT patients, either concurrently at the time of HT or in patients with a history of HT. In both groups, a temporal analysis of ICD placement rates and mean LOS did not show a significant trend from 2009 to 2018. However, results should be interpreted with caution because of the small cell counts and limited data points available. During this period, a mortality benefit, or harm, from
Disclosures
The authors have no conflicts of interest to declare.
References (18)
- et al.
The registry of the International Society for Heart and Lung Transplantation: twenty-eighth adult heart transplant report–2011
J Heart Lung Transplant
(2011) - et al.
2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
Heart Rhythm
(2018) - et al.
Implantable defibrillators and cardiac resynchronization therapy in heart transplant recipients: results of a national survey
J Heart Lung Transplant
(2009) - et al.
Impact of atrial fibrillation in patients with chronic kidney disease undergoing transcatheter aortic valve replacement: insights of the Healthcare Cost and Utilization Project's National Inpatient Sample
Cardiovasc Revasc Med
(2018) - et al.
Mode and mechanisms of death after orthotopic heart transplantation
Heart Rhythm
(2009) - et al.
Implantable cardioverter-defibrillators in a heart transplant population: a single-center experience
J Heart Lung Transplant
(2016) Sudden cardiac death after heart transplantation: can ICD prevent SCD?
Heart Rhythm
(2014)- et al.
Long-term follow-up of arrhythmia characteristics and clinical outcomes in heart transplant patients
Transplant Proc
(2013) - et al.
Cardiac implantable electronic devices following heart transplantation
JACC Clin Electrophysiol
(2020)
Cited by (2)
Pathophysiology and Management of Heart Failure in the Elderly
2022, International Journal of Angiology